Corporate Round - CureVac
Investment Firm
Overview
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.
Announced Date
Jul 20, 2020
Funding Type
Corporate Round
Highlights
Location
Europe
Social
Investor Lead
Participant Investors
1
| Investor Name |
|---|
Round Details and Background
CureVac raised $164590505 on 2020-07-20 in Corporate Round
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA.
Company Funding History
14
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Mar 05, 2015 |  Series E - CureVac | 1 | - | 76.0M |
| Sep 18, 2012 | Series D - CureVac | 1 | - | 104.4M |
| May 10, 2010 | Series C - CureVac | 1 | - | 34.9M |
| Jan 18, 2006 | Series B - CureVac | 2 | - | 26.6M |
Recent Activity
There is no recent news or activity for this profile.